MACK
Merrimack Pharmaceuticals, Inc.
MACK
MACK
Delisted
MACK was delisted on the 17th of May, 2024.
116 hedge funds and large institutions have $246M invested in Merrimack Pharmaceuticals, Inc. in 2017 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 31 increasing their positions, 41 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
116
Holders Change
-20
Holders Change %
-14.71%
% of All Funds
2.89%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
13
Increased
31
Reduced
41
Closed
26
Calls
$1.01M
Puts
$2.47M
Net Calls
-$1.45M
Net Calls Change
+$265K
Top Buyers
| 1 |
BlackRock
New York
|
$35.6M |
| 2 |
State Street
Boston,
Massachusetts
|
$20.4M |
| 3 |
Goldman Sachs
New York
|
$3.9M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
$31.6M |
| 5 |
AWCI
Alpine Woods Capital Investors
Purchase,
New York
|
$2.24M |
